The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer

DIRK RADES; BRITTA WARWAS; FLORIAN CREMERS; KARSTEN GERULL; RALPH PRIES; ANKE LEICHTLE; KARL L. BRUCHHAGE; SAMER G. HAKIM; STEVEN E. SCHILD

doi:10.21873/anticanres.15789

Article Information

vol. 42 no. 6 3035-3039

DOI

https://doi.org/10.21873/anticanres.15789

PMID

35641296

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received April 12, 2022
Revision received April 27, 2022
Accepted April 29, 2022
Published online May 31, 2022.

Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

DIRK RADES¹ ⇑,
BRITTA WARWAS¹,
FLORIAN CREMERS¹,
KARSTEN GERULL¹,
RALPH PRIES²,
ANKE LEICHTLE²,
KARL L. BRUCHHAGE²,
SAMER G. HAKIM³ and
STEVEN E. SCHILD⁴

¹Departments of Radiation Oncology, and Head and Neck Surgery
²Departments of Oto-Rhino-Laryngology and Head and Neck Surgery
³Oral and Maxillofacial Surgery, University of Lübeck, Lübeck, Germany;
⁴Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.

Correspondence to: Prof. Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de

View Full Text